---
title: "SARS-COV-2 VACCINE SUPPLY AGREEMENT"
ocid: "ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "BUSINESS ENERGY AND INDUSTRIAL STRATEGY"
published: "2021-02-12"
---

# SARS-COV-2 VACCINE SUPPLY AGREEMENT

Buyer: BUSINESS ENERGY AND INDUSTRIAL STRATEGY  
Current stage: Award  
OCID: ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633.json)

## Summary

The procurement process involves the Business Energy and Industrial Strategy as the buying organisation, which has completed a tender for a SARS-CoV-2 Vaccine Supply Agreement. This procurement falls under the goods category, specifically for vaccines, and is located in the United Kingdom. The contract, worth £1, was awarded to Novavax Inc. on 22nd October 2020, following a single tender action method, and the contract period extends until 31st December 2021.

This tender presents an opportunity for businesses in the pharmaceutical and healthcare sectors, particularly those involved in vaccine production and distribution. Companies with established capabilities in vaccine development, manufacturing, or related supply chain logistics would be well-suited to compete in future procurement processes of this nature, given the ongoing demand for innovative vaccine solutions.

## Notice

Procurement of Novavax's vaccine candidate NVX-CoV2373, as intended for the prophylaxis and vaccination against SARS-CoV-2 in humans. Note: This notice corrects and supersedes a previous notice (see links section). It does not represent a new arrangement or contract with the supplier. Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors . Contract end date is being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). The contract end date is variable based on production and delivery of the requirement. There are significant challenges to overcome and the end date may not be a true reflection, setting unrealistic expectation for the public and in the market. This information is also being withheld on due to commercial sensitivity under Regulation 50(6)(b) and (c) as there is significant competition to develop and bring to the market a successful vaccine. Provision of the contract term may provide valuable information to competitors that may impact negotiations or future competition in the market. Sub-contractor details are being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). This information is very sensitive given potential for targeting and disruption of the activities at the facilities which would be contrary to public interest as these activities are critical to success and delivery of the requirement.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/440445d9-888f-4b09-8fdf-465f913b7ca0 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Direct |
| Procurement method details | Single tender action (below threshold) |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 12 Feb 2021 |
| Submission deadline | 21 Oct 2020 |
| Future notice date | Not specified |
| Award date | 21 Oct 2020 |
| Contract period | 21 Oct 2020 - 31 Dec 2021 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £1 |
| Lots value | Not specified |
| Awards value | £1 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | BUSINESS ENERGY AND INDUSTRIAL STRATEGY |
| Locality | LONDON |
| Post town | South West London |
| Postcode | SW1H 0ET |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI3 Inner London - West |
| ITL 3 | TLI35 Westminster and City of London |
| Local authority | Westminster |
| Electoral ward | St James's |
| Westminster constituency | Cities of London and Westminster |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | NOVAVAX |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33651600 - Vaccines

## Release History

- 12 Feb 2021 at 17:15 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/440445d9-888f-4b09-8fdf-465f913b7ca0

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/440445d9-888f-4b09-8fdf-465f913b7ca0
  12th February 2021 - Awarded contract notice on Contracts Finder
- https://www.contractsfinder.service.gov.uk/Notice/c1ed715e-9a39-4263-961f-dc8166a81216
  This link refers to the original notice that is corrected and superseded by this notice.
- https://www.contractsfinder.service.gov.uk/Notice/SupplierAttachment/5b800abd-2b73-4bcd-be80-29567791f87e
  SARS-COV2 VACCINE SUPPLY AGREEMENT - [REDACTED]

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633.json.